5 Oversold Global Stocks To Buy

2. Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Latest 14 Day RSI Score: 16.27

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) is a Canadian firm that is developing treatments for tumors and for causes of tumors such as DNA damage. It missed first quarter EPS estimates by a wide margin, and analysts expect a 39 cent loss for the second quarter.

Insider Monkey’s Q1 2023 survey of 943 hedge funds revealed that 14 had held the firm’s shares. Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)’s biggest investor in our database is David Witzke and Michael Gregory’s Avidity Partners Management since it owns 5.7 million shares that are worth $21.4 million.

Follow Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)